Ben Ho Park, M.D., Ph.D.
The Donna S. Hall Chair in Breast Cancer, Professor of Medicine ,
Vanderbilt University Medical Center
Co-Leader Breast Cancer Research Program, Associate Director for Translational Research,Director of Precision Oncology - Vanderbilt-Ingram Cancer Center;
Interim Director, Division of Hematology/Oncology
Nashville, TN, USA
Dr. Park attended The University of Chicago for his A.B. degree, followed by dual training at The University of Pennsylvania School of Medicine where he received both his M.D. and Ph.D. degrees. Dr. Park then trained in Internal Medicine and Hematology/Oncology at The University of Pennsylvania prior to completing a post-doctoral fellowship in the laboratory of Dr. Bert Vogelstein at Johns Hopkins. Dr. Park then joined the faculty in the Breast Cancer Program at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and was Professor of Oncology, Associate Director of Education and Research Training and Associate Dean of Postdoctoral Affairs for the School of Medicine prior to joining Vanderbilt University Medical Center in 2018. He is currently the Donna S. Hall Chair in Breast Cancer, Professor of Medicine and Interim Director for the Division of Heme/Onc, Co-Leader of the Breast Cancer Research Program, Associate Director for Translational Research and Director of Precision Oncology at the Vanderbilt-Ingram Cancer Center. His research program involves identifying and validating genetic targets for breast cancer therapy and diagnostics. In particular, Dr. Park has pioneered the use of “liquid biopsies” to help guide future management of breast cancer therapies. He has also led the formation and implementation of molecular tumor boards at Hopkins and other institutions, and more recently at the Vanderbilt-Ingram Cancer Center.
Country: USA